IBEX Technologies Inc IBXNF:Grey Market

RT Quote | Exchange | USD
Last | 03/05/21 EST
0.23quote price arrow down-0.0517 (-18.3529%)
Volume
49,020
52 week range
0.10 - 0.30

...

Loading . . .

KEY STATS

  • Open0.2487
  • Day High0.25
  • Day Low0.23
  • Prev Close0.2817
  • 52 Week High0.30
  • 52 Week High Date02/16/21
  • 52 Week Low0.10
  • 52 Week Low Date03/06/20
  • Market Cap5.39M
  • Shares Out24.77M
  • 10 Day Average Volume11,920
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)0.03
  • P/E (TTM)7.56
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest IBEX Technologies Inc News

There is no recent news for this security.

Latest IBXNF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
IBEX Technologies Inc., through its subsidiaries, IBEX Pharmaceuticals Inc. and BioResearch Products Inc., manufactures and markets enzymes for biomedical use. The Company also manufactures and markets a series of arthritis assays, which enable the study of both the synthesis and degradation of cartilage components. It operates through the production and sale of diagnostic products segment. Its products include IB-C2C-HUSA, C2C Assay, CPII Assay, C1-2C Assay and CS-846 Assay....
Paul Baehr
Chairman
Address
Suite 100, 5485 Pare Street
Montreal, QC
H4P 1P7
Canada